Evidence map›Paper›PMID 23446460›Full record

ReviewZeitschrift fur Rheumatologie2013

[Magnetic resonance tomography and hybrid imaging in rheumatology].

C Buchbender, M Schneider, B Ostendorf

Abstract readComparative StudyEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C BuchbenderInstitut für Diagnostische und Interventionelle Radiologie, Heinrich-Heine-Universität Düsseldorf, Medizinische Fakultät, Düsseldorf, Deutschland.
M Schneider
B Ostendorf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In rheumatologic diseases magnet resonance imaging (MRI) is capable of depicting early inflammatory changes which are frequently missed by other imaging modalities. New MRI protocols and hardware, primarily whole-body MRI and low-field extremity MRI facilitate the use of MRI in rheumatology patients. The increasing number of functional MRI techniques provide additional molecular information on the tissue composition, e.g. cartilage quality. These molecular MRI techniques enable new ways for early disease detection and therapy monitoring. Hybrid imaging modalities, such as MRI-SPECT (single photon mmission tomography) and MRI-PET (positron emission tomography) provide a new level of molecular imaging in rheumatology by adding the advantages of the combined modalities. This article provides an up-to-date overview of new MRI techniques and innovative hybrid imaging modalities and summarizes the first available results of these procedures in rheumatologic applications.

Indexed as

Arthritis, RheumatoidCartilage, ArticularContrast MediaDiffusion Magnetic Resonance ImagingDisease ProgressionEarly DiagnosisEnergy MetabolismFollow-Up StudiesGadolinium DTPAHumansImage EnhancementImage Interpretation, Computer-AssistedJointsMagnetic Resonance ImagingPositron-Emission TomographySensitivity and SpecificityContrast MediaGadolinium DTPA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.